MENU
ETNB
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

89bio (ETNB) Earnings Date & Reports

89bio Inc is a United States-based clinical-stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases... Show more

A.I. Advisor
published Earnings

ETNB is expected to report earnings to fall 48.98% to -52 cents per share on May 07

89bio ETNB Stock Earnings Reports
Q1'25
Est.
$-0.52
Q4'24
Missed
by $0.27
Q3'24
Missed
by $0.77
Q2'24
Beat
by $0.08
Q1'24
Missed
by $0.08
The last earnings report on February 27 showed earnings per share of -101 cents, missing the estimate of -75 cents. With 1.77M shares outstanding, the current market capitalization sits at 1.00B.
View a ticker or compare two or three
ETNB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of innovative therapies for nonalcoholic steatohepatitis (NASH), liver and cardio-metabolic diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
142 Sansome Street
Phone
+1 415 432-9270
Employees
70
Web
https://www.89bio.com